Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine plus colchicine for moderate or severe COVID-19
RBR-8jyhxhPhase 3Completed
- Sponsor
- Hospital das Clínicas de Ribeirão Preto
- Start
- Apr 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Hydroxychloroquine + placebo with Hydroxychloroquine + colchicine (2 arms). Started Apr 2020; status: completed.
02
Drugs
hydroxychloroquinecolchicine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-8jyhxh.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8jyhxh.